| Y20180000969 | 吉非替尼 | gefitinib | Active ingredient | Other | Other | 2018-09-13 | | Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co Ltd | | | view |
| JYHZ2100748 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | License Renew | 2021-12-30 | | | | | view |
| JYHZ2100747 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | License Renew | 2021-12-30 | | | | | view |
| JYHS2200084 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2022-09-08 | | | | | view |
| JYHF1800003 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2018-01-16 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-02-13 | view |
| JYHB2002085 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-10-20 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-11-09 | view |
| JYHB2001691 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-09-04 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-09-15 | view |
| JYHB1800092 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2018-02-08 | | | Certificate Issued | 2018-07-10 | view |
| JYHB1800051 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2018-02-02 | | | Filed | 2018-02-08 | view |
| JYHB1701606 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2018-01-10 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2018-01-23 | view |
| JYHB1701605 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2017-12-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-01-08 | view |
| JYHB1600972 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2016-07-26 | | | Certificate Issued | 2017-12-18 | view |
| JYHB1501034 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2015-07-31 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2016-08-24 | view |
| JYHB1101276 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2011-12-31 | AstraZeneca KK | Astrazeneca Kk | Certificate Issued | 2012-11-08 | view |
| JYHB0701002 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2007-09-25 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2008-05-20 | view |
| JYHB0700891 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2007-09-05 | AstraZeneca KK Maihara Plant | Astrazeneca Kk Maihara Plant | Certificate Issued | 2008-04-30 | view |
| JYHB0600302 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2006-06-27 | AstraZenecaKK Maihara Plant | Astrazeneca Kk Maihara Plant | Certificate Issued | 2007-07-30 | view |
| JYHB0600136 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2006-03-10 | AstraZeneca Pty Ltd | Astrazeneca Pty Ltd | Certificate Issued | 2006-09-22 | view |
| JYHB0500150 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs | Supplementary Application | 2005-04-13 | AstraZeneca Pty Ltd | Astrazeneca Pty Ltd | Filed | 2005-10-12 | view |
| JXHS2000064 | 吉非替尼片 | gefitinib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-05-27 | 重庆嘉士腾医药有限公司 | Chongqing Kingmed Pharma Co Ltd | In Review | 2020-05-26 | view |
